Why the study?
Diagnosing stable ischemic heart disease is challenging, especially in females, and no diagnostic blood test is currently available.
Are plasma extracellular vesicle protein levels associated with stress-induced myocardial ischemia in patients presenting with chest pain?
Are plasma extracellular vesicle protein levels associated with stress-induced myocardial ischemia in patients presenting with chest pain?
Plasma extracellular vesicle proteins, particularly CD14 and Cystatin C, are associated with stress-induced myocardial ischemia specifically in women, highlighting a potential novel sex-specific diagnostic biomarker for stable ischemic heart disease.
Plasma EV proteins may aid stable IHD diagnosis; leaves open clinical utility pending prospective validation.
Diagnosing stable ischemic heart disease (IHD) is challenging, especially in females. Currently, no blood test is available. Plasma extracellular vesicles (EV) are emerging as potential biomarker source. We therefore aimed to identify stress induced ischemia due to stable IHD with plasma extracellular vesicle protein levels in chest pain patients. We analyzed 450 patients suspected for stable IHD who were referred for 82 Rb PET/CT in the outpatient clinic. Blood samples were collected before PET/CT and plasma EVs were isolated in 3 plasma subfractions named: TEX, HDL, LDL. In total 6 proteins were quantified in each of these subfractions using immuno-bead assays. CD14 and CystatinC protein levels were independent significant predictors of stress-induced ischemia in the LDL and the HDL subfraction and SerpinC1 and SerpinG1 protein levels in the HDL fraction. Subgroup-analysis on sex revealed that these associations were completely attributed to the associations in women. None of the significant EV proteins remained significant in men. Plasma EV proteins levels are associated with the presence of stable IHD in females presenting with chest pain. This finding, if confirmed in larger cohort studies could be a crucial step in improving diagnostic assessment of women with suspected IHD.
No takes yet. Share an insight, caveat, or question.
Dekker et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: